The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Early Cancer Screening Products Market Research Report 2024
Synopsis
Tumors are divided into benign tumors and malignant tumors. Cancer is a type of malignant tumor. Cancers mainly come from epithelial tissues, such as breast cancer, oral cancer, liver cancer and so on. Cancer screening is carried out between the "malignant tumor budding" and "malignant tumor activity" window periods.
The global Early Cancer Screening Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Early Cancer Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Early Cancer Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Early Cancer Screening Products in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Early Cancer Screening Products include EXACT Sciences Corporation, Epigenomics AG, Abbott Laboratories, Genomictree, oncgnostics GmbH, Qiagen, New Horizon Health, iStat Biomedical Co., Ltd and GRAIL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Early Cancer Screening Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Cancer Screening Products.
Report Scope
The Early Cancer Screening Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Early Cancer Screening Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Cancer Screening Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EXACT Sciences Corporation
Epigenomics AG
Abbott Laboratories
Genomictree
oncgnostics GmbH
Qiagen
New Horizon Health
iStat Biomedical Co., Ltd
GRAIL
Laboratory For Advanced Medicine Inc
Genetron Health
Berry Oncology
Segment by Type
Single Cancer
Pan Cancer
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Early Cancer Screening Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tumors are divided into benign tumors and malignant tumors. Cancer is a type of malignant tumor. Cancers mainly come from epithelial tissues, such as breast cancer, oral cancer, liver cancer and so on. Cancer screening is carried out between the "malignant tumor budding" and "malignant tumor activity" window periods.
The global Early Cancer Screening Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Early Cancer Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Early Cancer Screening Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Early Cancer Screening Products in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Early Cancer Screening Products include EXACT Sciences Corporation, Epigenomics AG, Abbott Laboratories, Genomictree, oncgnostics GmbH, Qiagen, New Horizon Health, iStat Biomedical Co., Ltd and GRAIL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Early Cancer Screening Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Cancer Screening Products.
Report Scope
The Early Cancer Screening Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Early Cancer Screening Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Early Cancer Screening Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EXACT Sciences Corporation
Epigenomics AG
Abbott Laboratories
Genomictree
oncgnostics GmbH
Qiagen
New Horizon Health
iStat Biomedical Co., Ltd
GRAIL
Laboratory For Advanced Medicine Inc
Genetron Health
Berry Oncology
Segment by Type
Single Cancer
Pan Cancer
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Early Cancer Screening Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Early Cancer Screening Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single Cancer
1.2.3 Pan Cancer
1.3 Market by Application
1.3.1 Global Early Cancer Screening Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Early Cancer Screening Products Market Perspective (2019-2030)
2.2 Early Cancer Screening Products Growth Trends by Region
2.2.1 Global Early Cancer Screening Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Early Cancer Screening Products Historic Market Size by Region (2019-2024)
2.2.3 Early Cancer Screening Products Forecasted Market Size by Region (2025-2030)
2.3 Early Cancer Screening Products Market Dynamics
2.3.1 Early Cancer Screening Products Industry Trends
2.3.2 Early Cancer Screening Products Market Drivers
2.3.3 Early Cancer Screening Products Market Challenges
2.3.4 Early Cancer Screening Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Early Cancer Screening Products Players by Revenue
3.1.1 Global Top Early Cancer Screening Products Players by Revenue (2019-2024)
3.1.2 Global Early Cancer Screening Products Revenue Market Share by Players (2019-2024)
3.2 Global Early Cancer Screening Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Early Cancer Screening Products Revenue
3.4 Global Early Cancer Screening Products Market Concentration Ratio
3.4.1 Global Early Cancer Screening Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Early Cancer Screening Products Revenue in 2023
3.5 Early Cancer Screening Products Key Players Head office and Area Served
3.6 Key Players Early Cancer Screening Products Product Solution and Service
3.7 Date of Enter into Early Cancer Screening Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Early Cancer Screening Products Breakdown Data by Type
4.1 Global Early Cancer Screening Products Historic Market Size by Type (2019-2024)
4.2 Global Early Cancer Screening Products Forecasted Market Size by Type (2025-2030)
5 Early Cancer Screening Products Breakdown Data by Application
5.1 Global Early Cancer Screening Products Historic Market Size by Application (2019-2024)
5.2 Global Early Cancer Screening Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Early Cancer Screening Products Market Size (2019-2030)
6.2 North America Early Cancer Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Early Cancer Screening Products Market Size by Country (2019-2024)
6.4 North America Early Cancer Screening Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Early Cancer Screening Products Market Size (2019-2030)
7.2 Europe Early Cancer Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Early Cancer Screening Products Market Size by Country (2019-2024)
7.4 Europe Early Cancer Screening Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Early Cancer Screening Products Market Size (2019-2030)
8.2 Asia-Pacific Early Cancer Screening Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Early Cancer Screening Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Early Cancer Screening Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Early Cancer Screening Products Market Size (2019-2030)
9.2 Latin America Early Cancer Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Early Cancer Screening Products Market Size by Country (2019-2024)
9.4 Latin America Early Cancer Screening Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Early Cancer Screening Products Market Size (2019-2030)
10.2 Middle East & Africa Early Cancer Screening Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Early Cancer Screening Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Early Cancer Screening Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EXACT Sciences Corporation
11.1.1 EXACT Sciences Corporation Company Detail
11.1.2 EXACT Sciences Corporation Business Overview
11.1.3 EXACT Sciences Corporation Early Cancer Screening Products Introduction
11.1.4 EXACT Sciences Corporation Revenue in Early Cancer Screening Products Business (2019-2024)
11.1.5 EXACT Sciences Corporation Recent Development
11.2 Epigenomics AG
11.2.1 Epigenomics AG Company Detail
11.2.2 Epigenomics AG Business Overview
11.2.3 Epigenomics AG Early Cancer Screening Products Introduction
11.2.4 Epigenomics AG Revenue in Early Cancer Screening Products Business (2019-2024)
11.2.5 Epigenomics AG Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Early Cancer Screening Products Introduction
11.3.4 Abbott Laboratories Revenue in Early Cancer Screening Products Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Genomictree
11.4.1 Genomictree Company Detail
11.4.2 Genomictree Business Overview
11.4.3 Genomictree Early Cancer Screening Products Introduction
11.4.4 Genomictree Revenue in Early Cancer Screening Products Business (2019-2024)
11.4.5 Genomictree Recent Development
11.5 oncgnostics GmbH
11.5.1 oncgnostics GmbH Company Detail
11.5.2 oncgnostics GmbH Business Overview
11.5.3 oncgnostics GmbH Early Cancer Screening Products Introduction
11.5.4 oncgnostics GmbH Revenue in Early Cancer Screening Products Business (2019-2024)
11.5.5 oncgnostics GmbH Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Detail
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Early Cancer Screening Products Introduction
11.6.4 Qiagen Revenue in Early Cancer Screening Products Business (2019-2024)
11.6.5 Qiagen Recent Development
11.7 New Horizon Health
11.7.1 New Horizon Health Company Detail
11.7.2 New Horizon Health Business Overview
11.7.3 New Horizon Health Early Cancer Screening Products Introduction
11.7.4 New Horizon Health Revenue in Early Cancer Screening Products Business (2019-2024)
11.7.5 New Horizon Health Recent Development
11.8 iStat Biomedical Co., Ltd
11.8.1 iStat Biomedical Co., Ltd Company Detail
11.8.2 iStat Biomedical Co., Ltd Business Overview
11.8.3 iStat Biomedical Co., Ltd Early Cancer Screening Products Introduction
11.8.4 iStat Biomedical Co., Ltd Revenue in Early Cancer Screening Products Business (2019-2024)
11.8.5 iStat Biomedical Co., Ltd Recent Development
11.9 GRAIL
11.9.1 GRAIL Company Detail
11.9.2 GRAIL Business Overview
11.9.3 GRAIL Early Cancer Screening Products Introduction
11.9.4 GRAIL Revenue in Early Cancer Screening Products Business (2019-2024)
11.9.5 GRAIL Recent Development
11.10 Laboratory For Advanced Medicine Inc
11.10.1 Laboratory For Advanced Medicine Inc Company Detail
11.10.2 Laboratory For Advanced Medicine Inc Business Overview
11.10.3 Laboratory For Advanced Medicine Inc Early Cancer Screening Products Introduction
11.10.4 Laboratory For Advanced Medicine Inc Revenue in Early Cancer Screening Products Business (2019-2024)
11.10.5 Laboratory For Advanced Medicine Inc Recent Development
11.11 Genetron Health
11.11.1 Genetron Health Company Detail
11.11.2 Genetron Health Business Overview
11.11.3 Genetron Health Early Cancer Screening Products Introduction
11.11.4 Genetron Health Revenue in Early Cancer Screening Products Business (2019-2024)
11.11.5 Genetron Health Recent Development
11.12 Berry Oncology
11.12.1 Berry Oncology Company Detail
11.12.2 Berry Oncology Business Overview
11.12.3 Berry Oncology Early Cancer Screening Products Introduction
11.12.4 Berry Oncology Revenue in Early Cancer Screening Products Business (2019-2024)
11.12.5 Berry Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Early Cancer Screening Products Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Single Cancer
Table 3. Key Players of Pan Cancer
Table 4. Global Early Cancer Screening Products Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Early Cancer Screening Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Early Cancer Screening Products Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Early Cancer Screening Products Market Share by Region (2019-2024)
Table 8. Global Early Cancer Screening Products Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Early Cancer Screening Products Market Share by Region (2025-2030)
Table 10. Early Cancer Screening Products Market Trends
Table 11. Early Cancer Screening Products Market Drivers
Table 12. Early Cancer Screening Products Market Challenges
Table 13. Early Cancer Screening Products Market Restraints
Table 14. Global Early Cancer Screening Products Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Early Cancer Screening Products Market Share by Players (2019-2024)
Table 16. Global Top Early Cancer Screening Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Cancer Screening Products as of 2023)
Table 17. Ranking of Global Top Early Cancer Screening Products Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Early Cancer Screening Products Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Early Cancer Screening Products Product Solution and Service
Table 21. Date of Enter into Early Cancer Screening Products Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Early Cancer Screening Products Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Early Cancer Screening Products Revenue Market Share by Type (2019-2024)
Table 25. Global Early Cancer Screening Products Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Early Cancer Screening Products Revenue Market Share by Type (2025-2030)
Table 27. Global Early Cancer Screening Products Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Early Cancer Screening Products Revenue Market Share by Application (2019-2024)
Table 29. Global Early Cancer Screening Products Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Early Cancer Screening Products Revenue Market Share by Application (2025-2030)
Table 31. North America Early Cancer Screening Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Early Cancer Screening Products Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Early Cancer Screening Products Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Early Cancer Screening Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Early Cancer Screening Products Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Early Cancer Screening Products Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Early Cancer Screening Products Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Early Cancer Screening Products Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Early Cancer Screening Products Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Early Cancer Screening Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Early Cancer Screening Products Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Early Cancer Screening Products Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Early Cancer Screening Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Early Cancer Screening Products Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Early Cancer Screening Products Market Size by Country (2025-2030) & (US$ Million)
Table 46. EXACT Sciences Corporation Company Detail
Table 47. EXACT Sciences Corporation Business Overview
Table 48. EXACT Sciences Corporation Early Cancer Screening Products Product
Table 49. EXACT Sciences Corporation Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 50. EXACT Sciences Corporation Recent Development
Table 51. Epigenomics AG Company Detail
Table 52. Epigenomics AG Business Overview
Table 53. Epigenomics AG Early Cancer Screening Products Product
Table 54. Epigenomics AG Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 55. Epigenomics AG Recent Development
Table 56. Abbott Laboratories Company Detail
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Early Cancer Screening Products Product
Table 59. Abbott Laboratories Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Genomictree Company Detail
Table 62. Genomictree Business Overview
Table 63. Genomictree Early Cancer Screening Products Product
Table 64. Genomictree Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 65. Genomictree Recent Development
Table 66. oncgnostics GmbH Company Detail
Table 67. oncgnostics GmbH Business Overview
Table 68. oncgnostics GmbH Early Cancer Screening Products Product
Table 69. oncgnostics GmbH Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 70. oncgnostics GmbH Recent Development
Table 71. Qiagen Company Detail
Table 72. Qiagen Business Overview
Table 73. Qiagen Early Cancer Screening Products Product
Table 74. Qiagen Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 75. Qiagen Recent Development
Table 76. New Horizon Health Company Detail
Table 77. New Horizon Health Business Overview
Table 78. New Horizon Health Early Cancer Screening Products Product
Table 79. New Horizon Health Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 80. New Horizon Health Recent Development
Table 81. iStat Biomedical Co., Ltd Company Detail
Table 82. iStat Biomedical Co., Ltd Business Overview
Table 83. iStat Biomedical Co., Ltd Early Cancer Screening Products Product
Table 84. iStat Biomedical Co., Ltd Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 85. iStat Biomedical Co., Ltd Recent Development
Table 86. GRAIL Company Detail
Table 87. GRAIL Business Overview
Table 88. GRAIL Early Cancer Screening Products Product
Table 89. GRAIL Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 90. GRAIL Recent Development
Table 91. Laboratory For Advanced Medicine Inc Company Detail
Table 92. Laboratory For Advanced Medicine Inc Business Overview
Table 93. Laboratory For Advanced Medicine Inc Early Cancer Screening Products Product
Table 94. Laboratory For Advanced Medicine Inc Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 95. Laboratory For Advanced Medicine Inc Recent Development
Table 96. Genetron Health Company Detail
Table 97. Genetron Health Business Overview
Table 98. Genetron Health Early Cancer Screening Products Product
Table 99. Genetron Health Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 100. Genetron Health Recent Development
Table 101. Berry Oncology Company Detail
Table 102. Berry Oncology Business Overview
Table 103. Berry Oncology Early Cancer Screening Products Product
Table 104. Berry Oncology Revenue in Early Cancer Screening Products Business (2019-2024) & (US$ Million)
Table 105. Berry Oncology Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Early Cancer Screening Products Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Early Cancer Screening Products Market Share by Type: 2023 VS 2030
Figure 3. Single Cancer Features
Figure 4. Pan Cancer Features
Figure 5. Global Early Cancer Screening Products Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Early Cancer Screening Products Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Early Cancer Screening Products Report Years Considered
Figure 11. Global Early Cancer Screening Products Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Early Cancer Screening Products Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Early Cancer Screening Products Market Share by Region: 2023 VS 2030
Figure 14. Global Early Cancer Screening Products Market Share by Players in 2023
Figure 15. Global Top Early Cancer Screening Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Cancer Screening Products as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Early Cancer Screening Products Revenue in 2023
Figure 17. North America Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Early Cancer Screening Products Market Share by Country (2019-2030)
Figure 19. United States Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Early Cancer Screening Products Market Share by Country (2019-2030)
Figure 23. Germany Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Early Cancer Screening Products Market Share by Region (2019-2030)
Figure 31. China Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Early Cancer Screening Products Market Share by Country (2019-2030)
Figure 39. Mexico Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Early Cancer Screening Products Market Share by Country (2019-2030)
Figure 43. Turkey Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Early Cancer Screening Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. EXACT Sciences Corporation Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 46. Epigenomics AG Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 47. Abbott Laboratories Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 48. Genomictree Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 49. oncgnostics GmbH Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 50. Qiagen Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 51. New Horizon Health Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 52. iStat Biomedical Co., Ltd Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 53. GRAIL Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 54. Laboratory For Advanced Medicine Inc Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 55. Genetron Health Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 56. Berry Oncology Revenue Growth Rate in Early Cancer Screening Products Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
